A Game Changing Oral Medicine For COVID From Merck Is Ready To Roll: Raymond Rupert patient advocate
Molnupiravir has just been approved by Britain’s national medicines regulatory agency—the first in the world to do so. Molnupiravir, made by Merck, a big pharma firm, and a Florida-based biotech called Ridgeback Biotherapeutics, is the first oral antiviral medicine available to treat covid-19. The approval marks another milestone in the ...